Results 121 to 130 of about 1,233,301 (210)

Cardiorenal Syndrome: Pathophysiology, Management, and the Challenge of Therapeutic Inertia. [PDF]

Medicina (Kaunas)
Gembillo G, Calabrese V, Soraci L, Lo Cicero L, Scapellato M, Messina R, Ricca MF, Stancanelli MR, Corsonello A, Santoro D.   +9 more
europepmc   +1 more source

Challenges of Biomarker Application in Patients with Cardiorenal Syndrome. [PDF]

Biomedicines
Khattab E, Kyriakou S, Karelas D, Ioannou M, Tatsis E, Bouzios P, Mitsis A, Papadopoulos CH, Kadoglou NPE.   +8 more
europepmc   +1 more source

Device therapies in cardiorenal syndrome: an expert review. [PDF]

ESC Heart Fail
Dauw J, Baudry G, Cobo Marcos M, Guzik M, Lopez JC, Bozkurt B, Iwanek G, Kobayashi M, Miró Ò, Myhre PL, Palazzuoli A, Testani JM, Metra M, Ponikowski P, Mullens W, Biegus J.   +15 more
europepmc   +1 more source

Growing public interest and regional disparities of cardiorenal syndrome in the United States. [PDF]

Front Digit Health
Schlesinger RP, Kashani KB, Thongprayoon C, Cheungpasitporn W, Miao J.   +4 more
europepmc   +1 more source

Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy-Part 1. [PDF]

Biomedicines
Mauriello A, Cetoretta V, Del Giudice C, Correra A, Maratea AC, Gioia R, Liccardo B, Esposito G, Russo V, D'Andrea A.   +9 more
europepmc   +1 more source

Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy-Part 2. [PDF]

Biomedicines
Mauriello A, Cetoretta V, Del Giudice C, Correra A, Maratea AC, Gioia R, Liccardo B, Esposito G, Russo V, D'Andrea A.   +9 more
europepmc   +1 more source

Prevalence of cardiorenal syndrome in type 2 diabetic patients. [PDF]

Bioinformation
Chaudhary S, Ahirwar B, Verma V, Parmar S.   +3 more
europepmc   +1 more source

An Integrated Therapeutic Strategy for Cardiorenal Syndrome to Target Oxidative Stress, Inflammation, and Fibrosis. [PDF]

Rev Cardiovasc Med
Wang X, He Q, Yang D, Guo Y, Fu S, He W.
europepmc   +1 more source

The role of proinflammatory mediators in anemia formation in patients with second type of cardiorenal syndrome

, 2012
At patients with cardiorenal syndrome anemia presence associated with a dysbalance of proinflammatory and anti-inflammatory link that testifies to an exhaustion of compensatory mechanisms, represented by ...
Титова, Ганна Юріївна, Риндіна, Наталія Геннадіївна   +1 more
core  

Highly viscous ascites prompting reconsideration of cardiorenal syndrome in a patient with advanced CKD after TAVI. [PDF]

CEN Case Rep
Yamada K, Koshida T, Abe K, Kobayashi T, Kihara M, Gohda T, Suzuki Y.   +6 more
europepmc   +1 more source